Efficacy of adepress (paroxetin) in generalized anxiety disorder

被引:0
作者
Chakhava, V. O. [1 ]
Budtueva, F. S. [1 ]
Borukaev, R. R. [1 ]
机构
[1] Serbsky Natl Res Ctr Social & Forens Psychiat, Moscow, Russia
关键词
generalized anxiety disorder; somatic anxiety; cognitive anxiety; treatment; adepress (paroxetin); IMIPRAMINE; TRIAL;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The aim of the study was to evaluate efficacy of adepress (paroxetin) in different clinical variants of generalized anxiety disorder (GAD). Adepress was used as a monotherapy during 42 days. Patient's state was assessed using Hamilton anxiety scale (HAM-A) at baseline and every week thereafter. The study included 49 patients aged 36,2 8,2 years. Patients were stratified into two groups according to the predominance of somatic (24 cases) or cognitive (21 cases) anxiety. The efficacy of adepress was shown both in a separate GAD and in a GAD with comorbid psychopathology. The effect of the drug was seen in patients with somatic anxiety after 3-4 weeks and in patients with cognitive anxiety after 3-6 weeks.
引用
收藏
页码:25 / 29
页数:5
相关论文
共 19 条
[1]  
AKHAPKIN RV, 2010, PSIKHIATRIYA PSIKHOF, V3, P61
[2]  
ALEKSANDROVSKY YUA, 1997, POGRANICHNYE PSIKH T, P579
[3]  
AVEDISOVA AS, 2006, CONSILIUM MEDICUM, V11, P14
[4]  
Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P53
[5]   Pharmacologic treatment of generalized anxiety disorder [J].
Brawman-Mintzer, O .
PSYCHIATRIC CLINICS OF NORTH AMERICA, 2001, 24 (01) :119-+
[6]  
CHAKHAVA VO, 2007, ROS MED ZHURN, V2, P85
[7]  
CHAKHAVA VO, 2007, ROS MED ZHURN, V15, P1860
[8]   Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder - A 6-month randomized controlled trial [J].
Gelenberg, AJ ;
Lydiard, RB ;
Rudolph, RL ;
Aguiar, L ;
Haskins, JT ;
Salinas, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (23) :3082-3088
[9]  
Hedges DW, 1996, PSYCHOPHARMACOL BULL, V32, P671
[10]  
HOEHNSARIC R, 1988, J CLIN PSYCHIAT, V49, P293